With the exceptions of STAD, TGCT, and PCPG, TSPAN4 exhibited aberrant expression across all tumor tissues relative to their corresponding normal tissues, with up-regulation in 12 tumors and down-regulation in 19 tumors (Figure 1A). Here, TSPAN4 is linked to neoplasm.